Dezocine analogue
US10414718B2 · kind B2 · utility
1Cited by
12References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 4, 2017 |
| Grant date | Sep 17, 2019 |
| Priority date | — |
| Expiry date | Jan 4, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/80
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed in the present disclosure is a Dezocine analog, and particularly disclosed are compounds represented by formula (I), (II) and (III), a pharmaceutically acceptable salt or tautomer thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.